CIITA and breast cancer: We further provide novel evidence that EZH2 contributes critical regulatory marks specifically to the silencing of CIITA transcription and to the regulation of MHC II expression in MDA MB 435 breast cancer cell variants, indicating EZH2 may play a role in promoting tumor growth through immunoevasion in the presence of inflammatory cytokine.